FIBRICOR (Caraco Pharma, Inc.)
Welcome to the PulseAid listing for the FIBRICOR drug offered from Caraco Pharma, Inc.. This Peroxisome Proliferator Receptor alpha Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Caraco Pharma, Inc. |
NON-PROPRIETARY NAME: | Fenofibric Acid |
SUBSTANCE NAME: | FENOFIBRIC ACID |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Peroxisome Proliferator Receptor alpha Agonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-08-14 |
END MARKETING DATE: | 0000-00-00 |
FIBRICOR HUMAN PRESCRIPTION DRUG Details:
Item Description | FIBRICOR from Caraco Pharma, Inc. |
LABELER NAME: | Caraco Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 35(mg/1) |
START MARKETING DATE: | 2009-08-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 49708-101_7a94885b-62b6-4db9-8d01-f594be8dba13 |
PRODUCT NDC: | 49708-101 |
APPLICATION NUMBER: | NDA022418 |
Other FENOFIBRIC ACID Pharmaceutical Manufacturers / Labelers: